elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36471685-3C4D353F-A69A-4799-96B0-43D9A2773D84
Q36471685-3C4D353F-A69A-4799-96B0-43D9A2773D84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36471685-3C4D353F-A69A-4799-96B0-43D9A2773D84
Targeted therapies in gastric cancer and future perspectives.
P2860
Q36471685-3C4D353F-A69A-4799-96B0-43D9A2773D84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36471685-3C4D353F-A69A-4799-96B0-43D9A2773D84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e540d2b711ca4b6c13a3f4489806557c6cf5e3f
P2860
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent